This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2011 Remove Analytical Chemistry Remove DNA Related Topics
Synthetic Chemistry Biochemical Assays Cell Based Assays Cell Biology Drug Development RNA Pharmaceuticals FDA Approval Clinical Development Licensing More Related Topics >
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

MARCH 7, 2023

Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Prior to Twist Bioscience, she worked at Agilent Technologies and at the University of Houston developing DNA and RNA parallel synthesis processes on solid support. She has published over 30 peer-reviewed papers.

International 246
International Science Pharmaceuticals DNA 246
article thumbnail

Transforming high-throughput screening with mass spectrometry

Drug Discovery World

OCTOBER 14, 2022

Wagner, MALDI imaging mass spectrometry: Bridging biology and chemistry in drug development, Bioanalysis, 2011, 3: 2427–2441, [link]. Büttner, MALDI-TOF mass spectrometry-based high-throughput screening for inhibitors of the cytosolic DNA sensor cGAS, SLAS Discovery, 2020, 25: 372–383, [link]. Castellino, M.R. Groseclose and D.

Synthetic Chemistry 130
Synthetic Chemistry Cell Based Assays Biochemical Assays Analytical Chemistry 130
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024